1001 Longitudinal changes in type 2 SLE activity

Similar Items

• 1115 The type 1 & 2 SLE model: the perspective of patients and rheumatologists
  by: Kai Sun, et al.
  Published: (2021-11-01)
• 303 Clinical and laboratory associations of longitudinal cell-bound complement activation products in SLE
  by: David S Pisetsky, et al.
  Published: (2024-05-01)
• 615 A pilot study to implement the Type 1 & 2 SLE Model into clinical care
  by: David S Pisetsky, et al.
  Published: (2022-12-01)
• Using PROMIS-29 to determine symptom burdens in the context of the Type 1 and 2 systemic lupus erythematosus (SLE) model: a cross sectional study
  by: Kai Sun, et al.
  Published: (2023-12-01)
• 1109 Clinical and laboratory manifestations of SLE patients with elevated cell-bound complement activation products
  by: John Conklin, et al.
  Published: (2021-11-01)